Please see full Prescribing Information, including Medication Guide: https://bit.ly/3RbtngD Here’s where you can find the latest information about IMBRUVICA®.
We will keep this page updated, so check back often. USES
What is IMBRUVICA® (ibrutinib)? IMBRUVICA® (ibrutinib) is a prescription medicine used to treat:
• Adults with chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL).
• Adults with chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL) with 17p deletion.
• Adults with Waldenström’s macroglobulinemia (WM).
• Adults and children 1 year of age and older with chronic graft versus host disease (cGVHD) after failure of 1 or more lines of systemic therapy. It is not known if IMBRUVICA® is safe and effective in children under 1 year of age. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Learn more at: www.IMBRUVICA.com. Read our Important Side Effect Information: https://www.imbruvica.com/
INDICATIONS
IMBRUVICA® (ibrutinib) is a kinase inhibitor indicated for the treatment of:
Adults with chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL). Adults with chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL) with 17p deletion. Adults with Waldenström’s macroglobulinemia (WM). Adults and children 1 year of age and older with chronic graft versus host disease (cGVHD) after failure of 1 or more lines of systemic therapy.
Be the first to know and let us send you an email when EvokeG posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
